"Tech Prophet" Who Predicted the iPhone Now Predicts...

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Cathie Wood's Ark Buys Roku, Palantir And $1M Worth Of Stock In This Healthcare Company

Shanthi Rexaline
April 10, 2024

Cathie Wood’s Ark Invest on Tuesday accumulated shares of a handful of companies spanning from technology to the healthcare sector.

Roku, Palantir Added: Ark through its Ark Innovation ETF (NYSE:ARKK) and Ark Next Generation Internet ETF (NYSE:ARKW), bought 12,647 shares of streaming device manufacturer Roku, Inc. (NASDAQ:ROKU). The purchase would have cost the firm $794,864 based on Roku’s closing price of $62.85.

Roku is the third biggest holding of Ark’s flagship ARKK exchange-traded fund. The fund holds about 9,018,582 Roku shares valued at $566.82 million, giving the stock a 7.68% weighting.

Ark’s ARK Space Exploration & Innovation ETF (CBOE: ARKX) bought 3,974 shares of Palantir Technologies, Inc. (NYSE:PLTR), an AI play, valued at $90,647. The purchase assumes importance because Ark has been continuously offloading shares of AI stalwart Nvidia Corp. (NASDAQ:NVDA).

See Also: Best ETFs To Buy Right Now

Teladoc In Favor: Ark continued to pile into telemedicine services company Teladoc Health, Inc. (NYSE:TDOC) for a second straight day. On Tuesday, through ARKK, ARKW, ARK Genomic Revolution ETF (CBOE: ARKG) and Ark Fintech Innovation ETF (NYSE:ARKF), the firm bought 68,122 Teladoc shares worth $1.03 million.

In a note previewing Teladoc’s upcoming first-quarter earnings, KeyBanc Capital Markets analyst Scott Schoenhaus said Wednesday he expects a mostly in-line quarter, but with notable weakness in the BetterHelp segment.

“We remain cautious given the steep profitability ramp built into FY guidance, plus decelerating momentum into the FY24 guidance in January,” the analyst said. The analyst isn’t confident about the longer term either, as he sees headwinds, including increasing competition, increasing costs, and pressures from more consumer-facing services at risk to forward estimates.

ARKK closed Tuesday’s session up 1.08% at $48.62, according to Benzinga Pro data. In premarket trading on Wednesday, the ETF added 0.33%.

Read Next: Tesla Back As Ark’s Darling: EV Giant Reclaims Top Spot In Cathie Wood’s Flagship Fund After Over 2 Years

Photo by viewimage on Shutterstock

Continue Reading...

Popular

Some Korean workers detained in Georgia immigration raid have returned to their jobs at Hyundai site

SAVANNAH, Ga. (AP) — Two months after 300 South Korean nationals were detained and left the U.S. following in an at Hyundai's electric vehicle manufacturing site in Georgia, some of those workers have returned to America to resume those jobs, their employer said Thursday.

Tradr Expands Leveraged Lineup With 4 New Single-Stock ETFs Targeting AI Infrastructure Firms

The new ETFs offer 2x exposure to Bloom Energy, Celestica, NANO Nuclear Energy, and Synopsys—each linked to America's expanding AI infrastructure.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Zohran Mamdani Says No More Thanking Veterans Today, Forgetting Tomorrow — Trump, Obama And Others Express Gratitude For Service

America's top political and tech leaders — including Donald Trump, Barack Obama, Tim Cook, and Sundar Pichai — marked Veterans Day 2025 with tributes honoring the courage and sacrifice of U.S. service members.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

AutoZone's Domestic 'Do It For Me' Business Driving Market Share Gains

Goldman Sachs upgrades AutoZone to Buy after recent sell-off, highlighting double-digit domestic DIFM growth, share gains, and long-term EPS upside through FY28.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Trump Tells Republicans To Not Be 'Weak:' 'You Will Rue The Day That You Didn't Terminate The…'

Trump urges Republicans to end filibuster and warns of Democratic plans to expand Supreme Court. Government shutdown continues.

Nasdaq 100 Faces Worst November Since 2008 As AI Boom Hits A Wall

The Nasdaq 100 is breaking its bullish November streak as AI infrastructure bottlenecks, led by CoreWeave, shake up 2025 tech market performance.

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

Jury awards $28M to family of a United Nations consultant killed in Boeing 737 Max crash in Ethiopia

A federal court jury has awarded more than $28 million to the family of a woman who died in the crash of a Boeing 737 Max jetliner in Ethiopia more than six years ago.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

All 14 victims identified from fiery UPS cargo plane crash in Louisville

LOUISVILLE, Ky. (AP) — A grandfather and his young granddaughter. An electrician with two young children. A woman standing in line at a scrap metal business.

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

The New Gold Trade Dominating on Wall Street - Ad

Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)

Visa Launches Stablecoin Payouts For The Gig Economy As Traders Eye $343

Visa Inc. (NYSE:V) is shaking up digital payments with a new pilot program that lets creators, freelancers, and gig workers receive instant USDC stablecoin payouts

A Vermont cycling apparel company is trying to survive Trump's tariffs. Will the Supreme Court help?

BURLINGTON, Vt. (AP) — From the moment President Donald Trump on nearly every country, Nik Holm feared the company he leads might not survive.

Buy This Stock Tomorrow? - Ad

A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.

Mark Zuckerberg's Patience 'Ran Out': Hyperbolic CTO Says Yann LeCun's Meta Exit Was Inevitable After $15 Billion Alexandr Wang Deal

Hyperbolic CTO Yuchen Jin claimed that Yann LeCun's reported exit from Meta was inevitable after Mark Zuckerberg's $15 billion acquisition of Alexandr Wang, signaling a power shift in Meta's AI strategy from long-term research to aggressive, product-driven innovation.

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners

Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.

Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad

Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.

Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails

Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.

Court Blocks Trump's SNAP Reductions, But Stricter Eligibility Rules Begin

New work requirements for SNAP begin Saturday, but benefits may not be issued through November due to the government shutdown.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Trump no-show at big Asian economic forum may risk US reputation in region

GYEONGJU, South Korea (AP) — A hot mike caught U.S. President Donald Trump saying that his much-anticipated meeting Thursday , meant to settle the most important trade relationship in the world, would be “three, four hours” and he would then fly back to Washington.

A medley of tech gifts for everyone on your holiday shopping list

NEW YORK (AP) — It's the most wonderful time of the year, unless you want to find the perfect gifts for .

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Meta, Alphabet, Chipotle, Microsoft And Starbucks: Why These 5 Stocks Are On Investors' Radars Today

Major stock indexes traded mixed on Wednesday, with the Dow Jones Industrial Average slipping nearly 0.2% to 47,632 and the S&P 500 holding steady at 6,890.59.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

16 Stocks To Buy If You Want To Escape The AI Hype

Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.

Transportation Secretary Sean Duffy warns of 'mass chaos' in skies if shutdown continues

Transportation Secretary Sean Duffy predicted Tuesday that there could be chaos in the skies next week if the government shutdown drags on and air traffic controllers miss a second paycheck.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Fintech company Fiserv slashes guidance, shuffles leadership after big earnings miss

WASHINGTON (AP) — Fiserv shares careened to their lowest level in more than five years Wednesday after the fintech payment company badly missed Wall Street's profit targets, lowered its forecast and announced a shake-up in leadership.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service